人工 T 細胞市場：按類型、用途和最終用戶分類 - 2023-2030 年全球預測

預計2023年全球人工T細胞市場將達27.312億美元，複合年成長率為25.70%，大幅成長，2030年將達到135.6028億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球工程T細胞市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球人工T細胞市場規模及預測為何？

2.在預測期內，COVID-19對全球人工T細胞市場的阻礙因素與影響為何？

3. 在預測期內，全球人工 T 細胞市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球人工T細胞市場的競爭策略是什麼？

5. 全球人工T細胞市場的技術趨勢和法律規範是什麼？

6.全球人工T細胞市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球工程T細胞市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 癌症盛行率上升
    • 對創新生物製藥治療的需求不斷增加
    • CAR-T細胞工程的最新進展
  • 抑制因素
    • 處理人工 T 細胞的成本較高
  • 機會
    • 研發經費推動腫瘤免疫學領域蓬勃發展
    • 擴大基因治療市場空間
  • 任務
    • 人工 T 細胞的安全問題與可能的副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 人工 T 細胞市場：依類型

• 嵌合抗原受體
• T細胞受體
• 腫瘤浸潤淋巴細胞

第7章 人工 T 細胞市場：依用途

• 乳癌
• 大腸直腸癌
• 白血病
• 肺癌
• 黑色素瘤

第8章 人工 T 細胞市場：依最終用戶分類

• 癌症研究中心
• 診所
• 醫院

第9章 美洲人工T細胞市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太人工T細胞市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲人工T細胞市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Engineered T Cells Market is forecasted to grow significantly, with a projected USD 2,731.20 million in 2023 at a CAGR of 25.70% and expected to reach a staggering USD 13,560.28 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Engineered T Cells Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Engineered T Cells Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Chimeric Antigen Receptor, T Cell Receptor, and Tumor-Infiltrating Lymphocytes. The Chimeric Antigen Receptor is projected to witness significant market share during forecast period.

Based on Application, market is studied across Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, and Melanoma. The Breast Cancer is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Cancer Research Centers, Clinics, and Hospitals. The Cancer Research Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Engineered T Cells Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Engineered T Cells Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Engineered T Cells Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Engineered T Cells Market?

4. What is the competitive strategic window for opportunities in the Global Engineered T Cells Market?

5. What are the technology trends and regulatory frameworks in the Global Engineered T Cells Market?

6. What is the market share of the leading vendors in the Global Engineered T Cells Market?

7. What modes and strategic moves are considered suitable for entering the Global Engineered T Cells Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Engineered T Cells Market, by Type, 2022 vs 2030
• 4.3. Engineered T Cells Market, by Application, 2022 vs 2030
• 4.4. Engineered T Cells Market, by End-User, 2022 vs 2030
• 4.5. Engineered T Cells Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in prevalence of cancer diseases
    • 5.1.1.2. Increasing demand for innovative biopharmaceutical therapies
    • 5.1.1.3. Recent advances in CAR-T cell engineering
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated to engineered T cells treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Immuno-oncology sector booming with R&D funding
    • 5.1.3.2. Expanding gene therapy marketspace
  • 5.1.4. Challenges
    • 5.1.4.1. Safety issues and possible side-effects with engineered T cells
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Engineered T Cells Market, by Type

• 6.1. Introduction
• 6.2. Chimeric Antigen Receptor
• 6.3. T Cell Receptor
• 6.4. Tumor-Infiltrating Lymphocytes

7. Engineered T Cells Market, by Application

• 7.1. Introduction
• 7.2. Breast Cancer
• 7.3. Colorectal Cancer
• 7.4. Leukemia
• 7.5. Lung Cancer
• 7.6. Melanoma

8. Engineered T Cells Market, by End-User

• 8.1. Introduction
• 8.2. Cancer Research Centers
• 8.3. Clinics
• 8.4. Hospitals

9. Americas Engineered T Cells Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Engineered T Cells Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Engineered T Cells Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ENGINEERED T CELLS MARKET RESEARCH PROCESS
• FIGURE 2. ENGINEERED T CELLS MARKET SIZE, 2022 VS 2030
• FIGURE 3. ENGINEERED T CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. ENGINEERED T CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. ENGINEERED T CELLS MARKET DYNAMICS
• FIGURE 9. ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ENGINEERED T CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ENGINEERED T CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. ENGINEERED T CELLS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. ENGINEERED T CELLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. ENGINEERED T CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. ENGINEERED T CELLS MARKET SIZE, BY CHIMERIC ANTIGEN RECEPTOR , BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. ENGINEERED T CELLS MARKET SIZE, BY T CELL RECEPTOR , BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ENGINEERED T CELLS MARKET SIZE, BY TUMOR-INFILTRATING LYMPHOCYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. ENGINEERED T CELLS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ENGINEERED T CELLS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ENGINEERED T CELLS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ENGINEERED T CELLS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ENGINEERED T CELLS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. ENGINEERED T CELLS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. ENGINEERED T CELLS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ENGINEERED T CELLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ENGINEERED T CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENGINEERED T CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ENGINEERED T CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ENGINEERED T CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ENGINEERED T CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. ENGINEERED T CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 146. ENGINEERED T CELLS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 147. ENGINEERED T CELLS MARKET LICENSE & PRICING